Medication info

PolabuFen Injection (Ibuprofen)

Prescription medicationExpired
Ingredient · strength
Ibuprofen›Strength being verified
Manufacturer / importer
Hanol Biopharma Co., Ltd.
Appearance
A colorless or pale yellow transparent liquid injection in a colorless transparent glass vial.
Packaging
4 mL/vial x 10 vials, 8 mL/vial x 10 vials
Approval status
Expired

MFDS item code 201802437 · Notified 2018.06.12

This product's status changed to Expired on 2023.06.12. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Adjunctive therapy with opioid analgesics for moderate to severe pain; relief of fever
Who uses it
Adults · Children
Adult dosage
Administer this medicine at the lowest effective dose that meets the treatment goal for each patient, for the shortest possible duration. After the initial administration, adjust the dose and frequency of administration appropriately according to the patient's condition. Adults may receive up to 3200mg per day. To reduce the risk of renal adverse reactions, ensure that the patient is adequately hydrated before administration. (1) Adjunctive therapy to opioid analgesics (morphine) for the management of moderate to severe pain Adults (17 years and older): Administer 400mg-800mg intravenously every 6 hours as needed. Up to 3200mg per day may be administered. The infusion time must be at least 30 minutes. (2) Fever reduction Adults (17 years and older): Administer 400mg intravenously every 4-6 hours as needed. Depending on the patient's condition, after an initial dose of 400mg, 100-200mg may be administered every 4 hours. Up to 3200mg per day may be administered. The infusion time must be at least 30 minutes. <Preparation of intravenous infusion solution> Before intravenous infusion, dilute with an intravenous fluid to a final concentration of 4mg/mL or less. The following intravenous fluids may be used: 0.9% sodium chloride injection, 5% dextrose injection, or lactated Ringer's solution. ㆍ400mg solution: Dilute 4mL of this medicine in at least 100mL of intravenous fluid. ㆍ800mg solution: Dilute 8mL of this medicine in at least 200mL of intravenous fluid. The diluted intravenous infusion solution is stable for 24 hours at 20-25℃ under indoor lighting conditions. Before administration, visually inspect the injection for particulate matter and discoloration. Do not use if opaque particles, other contaminants, or discoloration are observed.
Children's dosage
6 months to under 12 years: Administer 10mg/kg per dose (maximum 400mg) intravenously every 4~6 hours as needed; the administration time must be at least 10 minutes. Up to 40mg/kg or 2,400mg per day may be administered (whichever dose is lower). 12 years to under 17 years: Administer 400mg per dose intravenously every 4~6 hours as needed; the administration time must be at least 10 minutes. Up to 2,400mg per day may be administered.

Ingredients

Manufacturer
Hanol Biopharma Co., Ltd.

Efficacy & effects

Adjunctive therapy with opioid analgesics for moderate to severe pain; relief of fever

  • Moderate pain
  • severe pain
  • fever
View approved original text

This medication is used as an adjunct therapy to control moderate to severe pain in conjunction with opioid analgesics. It also has antipyretic effects and helps to reduce fever. Therefore, it is used for effective treatment in both pain relief and fever control.

Dosage and Administration

Adult dosage

Administer this medicine at the lowest effective dose that meets the treatment goal for each patient, for the shortest possible duration. After the initial administration, adjust the dose and frequency of administration appropriately according to the patient's condition. Adults may receive up to 3200mg per day. To reduce the risk of renal adverse reactions, ensure that the patient is adequately hydrated before administration. (1) Adjunctive therapy to opioid analgesics (morphine) for the management of moderate to severe pain Adults (17 years and older): Administer 400mg-800mg intravenously every 6 hours as needed. Up to 3200mg per day may be administered. The infusion time must be at least 30 minutes. (2) Fever reduction Adults (17 years and older): Administer 400mg intravenously every 4-6 hours as needed. Depending on the patient's condition, after an initial dose of 400mg, 100-200mg may be administered every 4 hours. Up to 3200mg per day may be administered. The infusion time must be at least 30 minutes. <Preparation of intravenous infusion solution> Before intravenous infusion, dilute with an intravenous fluid to a final concentration of 4mg/mL or less. The following intravenous fluids may be used: 0.9% sodium chloride injection, 5% dextrose injection, or lactated Ringer's solution. ㆍ400mg solution: Dilute 4mL of this medicine in at least 100mL of intravenous fluid. ㆍ800mg solution: Dilute 8mL of this medicine in at least 200mL of intravenous fluid. The diluted intravenous infusion solution is stable for 24 hours at 20-25℃ under indoor lighting conditions. Before administration, visually inspect the injection for particulate matter and discoloration. Do not use if opaque particles, other contaminants, or discoloration are observed.

Children's dosage

6 months to under 12 years: Administer 10mg/kg per dose (maximum 400mg) intravenously every 4~6 hours as needed; the administration time must be at least 10 minutes. Up to 40mg/kg or 2,400mg per day may be administered (whichever dose is lower). 12 years to under 17 years: Administer 400mg per dose intravenously every 4~6 hours as needed; the administration time must be at least 10 minutes. Up to 2,400mg per day may be administered.

Precautions

This drug can affect heart and vascular health, so it should be used with caution in individuals with cardiovascular disease or risk factors. The potential for serious issues like heart attack or stroke may arise during treatment, so patients should closely monitor symptoms. There is a risk of gastrointestinal bleeding or ulcers, so caution is advised for those with a history of gastrointestinal disorders or the elderly. If gastrointestinal-related adverse effects occur, immediate consultation with healthcare professionals is necessary. This medication should not be used in patients with gastrointestinal bleeding or ulcers, severe blood disorders, or significant liver, kidney, or heart dysfunction. Patients with a history of allergic reactions or asthma should avoid this drug. It should not be used in late pregnancy as it may harm the fetus. It is safest not to use this drug with other non-steroidal anti-inflammatory drugs (NSAIDs). Patients with hypertension or heart failure should closely monitor blood pressure and heart condition while taking this medication. Patients with impaired kidney function should be cautious, as taking the drug in a dehydrated state may lead to kidney damage. Patients with liver dysfunction or a history of liver disease should carefully monitor liver function while taking this medication. Anemia may appear in blood tests, so it is necessary to check blood status during prolonged use. This drug may cause allergic reactions, so if symptoms like rash or difficulty breathing occur, the medication should be stopped immediately and healthcare professionals informed. This drug may mask infection symptoms, so caution is warranted when diagnosing suspected infections. Taking it with aspirin or other anticoagulants may increase the risk of bleeding, so one should consult with a physician. This drug may interact with specific medications, so it is essential to inform healthcare professionals of any other drugs being taken. Pregnant or nursing women should consult with a healthcare provider before using this medication and particularly avoid it during the later stages of pregnancy. Safety has not been established for infants under 6 months so use is discouraged in this age group. Elderly patients may experience decreased physical function, necessitating dose adjustments and regular monitoring. Overdose may result in serious side effects such as dizziness, vomiting, liver dysfunction, and kidney failure, so the prescribed dosage must be strictly followed. If an overdose is suspected, immediate medical attention should be sought.

Side effects

  • Shock
  • anaphylactic reactions
  • mimicking concerns
  • chills
  • shortness of breath
  • hypotension
  • decreased hematocrit
  • decreased hemoglobin
  • anemia
  • aplastic anemia
Show 134 more
  • hemolytic anemia
  • agranulocytosis
  • granulocytopenia
  • leukopenia
  • thrombocytopenia
  • impaired platelet function
  • eosinophilia
  • peptic ulcers
  • gastrointestinal ulcers
  • gastrointestinal bleeding
  • perforation
  • ulcerative colitis
  • bloody stools
  • gastritis
  • pancreatitis
  • hematemesis
  • Crohn's disease
  • loss of appetite
  • nausea
  • vomiting
  • abdominal pain
  • dyspepsia
  • diarrhea
  • discomfort in the upper abdomen
  • epigastric pain
  • thirst
  • stomatitis
  • abdominal distension
  • oral ulcers
  • constipation
  • melena
  • skin and mucous membrane syndrome
  • toxic epidermal necrolysis
  • photosensitivity reactions
  • drug rash
  • angioedema
  • vesicular dermatitis
  • erythema multiforme
  • papular rash
  • skin reddening
  • vesicles
  • rash
  • hepatitis
  • jaundice
  • liver dysfunction
  • liver impairment
  • hypersensitivity
  • asthma attacks
  • urticaria
  • eczema
  • purpura
  • rash
  • itching
  • asthma
  • bronchoconstriction
  • shortness of breath
  • wheezing
  • scotoma
  • hearing loss
  • tinnitus
  • taste disturbance
  • dizziness
  • drowsiness
  • light-headedness
  • depression
  • headache
  • cerebrovascular accident
  • irritability
  • aseptic meningitis
  • hypertension
  • palpitations
  • heart failure
  • myocardial infarction
  • angina
  • acute kidney failure
  • oliguria
  • hematuria
  • proteinuria
  • elevated serum creatinine
  • hyperkalemia
  • interstitial nephritis
  • nephrotic syndrome
  • renal papillary necrosis
  • decreased urine output
  • generalized edema
  • dyspnea
  • malaise
  • periorbital edema
  • facial edema
  • fatigue
  • fever
  • epistaxis
  • edema
  • peripheral edema
  • nausea
  • vomiting
  • bloating
  • headache
  • hemolysis
  • drowsiness
  • peripheral edema
  • urinary disturbances
  • anemia
  • decreased hemoglobin
  • dyspepsia
  • wound hemolysis
  • abdominal discomfort
  • cough
  • hypokalemia
  • anemia
  • eosinophilia
  • hypoalbuminemia
  • neutropenia
  • increased hematuria
  • hypernatremia
  • hypertension
  • hypoalbuminemia
  • hypotension
  • diarrhea
  • bacterial pneumonia
  • increased serum LDH
  • thrombocytosis
  • bacteremia
  • injection site pain
  • nausea
  • dizziness
  • abdominal pain
  • hyperkalemia
  • metabolic acidosis
  • loss of consciousness
  • convulsions
  • renal failure
  • respiratory depression
  • hypotension

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a sealed container to prevent exposure to air or moisture, and the storage temperature should be maintained at room temperature between 1°C and 30°C. Proper storage will help maintain the drug's effectiveness.

Appearance and packaging

Appearance

A colorless or pale yellow transparent liquid injection in a colorless transparent glass vial.

Package unit

4 mL/vial x 10 vials, 8 mL/vial x 10 vials

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.